This site is intended for healthcare professionals only

Issue:

Share this article
Share on facebook
Share on twitter
Share on email
Share on print

Need to know guide: SGLT2 inhibitor indications, doses and licences

Pam Brown
A printable guide to SGLT2 inhibitors, organised by drug and by indication.

Share this article
Share on facebook
Share on twitter
Share on whatsapp
Share on email
Share on print

Need to know is a new series of rapid-reference memory aids from Diabetes & Primary Care. In this latest guide, Pam Brown summarises the doses, indications and licences of the SGLT2 inhibitor class of diabetes drugs.

Readers are directed to the PDF version.

Publisher’s note: This guide is now out of date. An updated version is available here.

For the latest news and articles

Sign up to all DiabetesontheNet journals

© Copyright Omniamed Communications. All Rights Reserved​
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom​
Omniamed logo white
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

DiabetesontheNet Logo

This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.